What is the stage of undifferentiated nasopharyngeal carcinoma and how to treat it

What is the stage of undifferentiated nasopharyngeal carcinoma? How to treat it?

Nasopharyngeal carcinoma is a malignant tumor that occurs in the nasopharyngeal mucosa. Common clinical symptoms include nasal congestion, bloody nose, headache, and tinnitus. Undifferentiated type is one of them. The cancer cells are small, with less cytoplasm, and are round or short spindle-shaped. The cancer cells are diffusely distributed without obvious cancer nest formation. It is highly malignant.

The higher the degree of differentiation, the closer it is to normal cells, and the lower the malignancy. Undifferentiated ones are very malignant. Usually, undifferentiated nasopharyngeal carcinoma is divided into stage I, stage II, and stage III.

Treatment for this type of nasopharyngeal cancer is as follows:

1. The first choice for the treatment of nasopharyngeal carcinoma is radiotherapy, supplemented by surgery, chemotherapy and conservative treatment of traditional Chinese medicine. The treatment options for nasopharyngeal carcinoma are relatively mature and most are effective. Ginsenoside RH2 can also be used to improve the success rate of treatment and reduce the recurrence and metastasis of tumors.

2. Chinese and Western medicine have their own strengths in treating tumors. Therefore, in treating nasopharyngeal carcinoma, we must give full play to the advantages of both Chinese and Western medicines, insist on long-term treatment, relax the patient's psychological state, do a good job of psychological treatment, increase dietary nutrition, and improve the patient's immune function. Only in this way can we achieve better results.

3. Among the cases of nasopharyngeal carcinoma, most are in the middle and late stages. In addition, about 60% of them will have symptoms of recurrence and metastasis within 3 years after treatment. Therefore, after western medicine treatment, combined with ginsenoside RH2, it can effectively enhance efficacy and reduce toxicity, shorten the recovery period, and prevent recurrence and metastasis. The current survival period of nasopharyngeal carcinoma is still relatively good.